methylnitrosourea has been researched along with 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borodkina, AG; Egorov, GN; Gorbunova, VA; Manziuk, LV; Orel, NF; Semina, OV | 1 |
| Akimov, MA; Gershanovich, ML | 1 |
| Gorbunova, VA; Kuz'minov, AE; Naskhletashvili, DR | 1 |
| Lesnaia, NA; Pokrovskiĭ, VS; Romanenko, VI; Treshchalina, EM | 1 |
| Bodiagin, DA; Pokrovskiĭ, VS; Treshchalin, MI; Treshchalina, EM | 1 |
| Afanasyeva, D; Baryshnikova, M; Belyаvsky, A; Burova, O; Misyurin, V; Shprakh, Z; Vartanian, A | 1 |
1 review(s) available for methylnitrosourea and 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea
| Article | Year |
|---|---|
[Combination chemotherapy with newly-developed cytostatics for disseminated small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Glycosides; Humans; Irinotecan; Lung Neoplasms; Male; Methylnitrosourea; Middle Aged; Taxoids; Treatment Outcome | 2007 |
1 trial(s) available for methylnitrosourea and 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea
| Article | Year |
|---|---|
[Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Glycosides; Humans; Immunologic Factors; Interferon-alpha; Male; Melanoma; Methylnitrosourea; Middle Aged; Skin Neoplasms; Treatment Outcome | 2004 |
4 other study(ies) available for methylnitrosourea and 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea
| Article | Year |
|---|---|
[Aranoza -- a new Russian antineoplastic drug].
Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Glycosides; Humans; Infusions, Intra-Arterial; Interferon-alpha; Melanoma; Methylnitrosourea; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Time Factors | 2001 |
[Pre-clinical study of combined aranosa, cisplatin and irinotecan in the treatment of experimental lung cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Lewis Lung; Cisplatin; Drug Administration Schedule; Glycosides; Irinotecan; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred Strains | 2009 |
[Hematological toxicity of some combined chemotherapy schemes involving aranoza].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Etoposide; Glycosides; Hematologic Tests; Irinotecan; Lymphopenia; Male; Methylnitrosourea; Mice; Mice, Inbred BALB C; Neutropenia; Topotecan | 2010 |
Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; CD24 Antigen; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoglin; Fluorescent Dyes; Gene Expression; Glycosides; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Male; Melanoma; Methylnitrosourea; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Nuclear Proteins; Phenotype; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-kit; Rhodamine 123; Tetraspanin 30 | 2017 |